Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
SPRC, Financing: Sparc Ltd. Closes $1.3 Million Underwritten Public Offering
News ReleaseTEL AVIV, Israel, Aug. 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“SciSparc” or the “Company”) today announced the closing of a firm commitment underwritten public offering with gross proceeds to the Company of approximately $1.3 million, before deducting underwriting discounts and other estimated expenses payable by the Company. The base offering consisted of 6,500,000 ordinary shares (or pre-funded warrants in lieu of ordinary shares) at a price to the public of $0.20 per share (or $0.199 per pre-funded warrant). The Company intends to use the net proceeds from this offering primarily for working capital.F
Will do Big R/S, then, do financing Again. Be careful.
Sold half of CNXA at 0.2553. Sweet.
Yep. Bought CNXA at 7 cents yesterday. Watching it dancing.
CNXA, 0.24, good run. my 7 cents now tripled .
CNXA, good run. my 7 cents now tripled .
GRTX, might break through back to $2 with this inspiring meeting with FDA on Sep 28.
Galera Schedules Type A Meeting with FDA to Discuss Next Steps for Avasopasem
2023-09-18 07:00 ET - News Release
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that a Type A Meeting has been scheduled for September 28, 2023 with the U.S. Food and Drug Administration (FDA) regarding the Complete Response Letter (CRL) received for the Company’s New Drug Application (NDA) for avasopasem manganese (avasopasem). The FDA is expected to issue written meeting minutes approximately 30 days following the meeting.
"We look forward to further understanding the FDA’s review of our NDA for avasopasem and the data from our two randomized placebo-controlled clinical trials,” said Mel Sorensen, M.D., Galera’s President and CEO. “We believe in avasopasem’s potential to bring meaningful benefit to patients with head and neck cancer suffering from severe oral mucositis. With clarity on the perspective of the FDA reviewers from the meeting and subsequent minutes, we hope to identify necessary steps to bring avasopasem to these patients.”
The Company intends to gain an understanding from the FDA of its evaluation of avasopasem for radiotherapy-induced severe oral mucositis (SOM) in patients with head and neck cancer undergoing standard-of-care treatment and next steps to support an NDA resubmission. The Type A Meeting is the highest priority classification of meeting that the FDA grants to NDA sponsors.
CGA, Trading, grabbed some more.
Just place an order at limited pps, it would be filled when it is traded and reach your pps.
CCG, Touched $200. Let’s see whether it will touch $500 as some Wallstreets saying.
CCG, Chinese Auto markets are Vast! That’s why CCG skyrocketing.
CCG, just found this: it’s a Chinese Auto Insurance Company with huge assets. Listed today with tint O/S.
WoW! CCG getting crazy! Some saying it’s going to $500, with tiny float.
AWIN going to file Bankruptcy after close?
Wow! LIFW, doing Huge R/S: 1:300,
common stock at a reverse stock split ratio ranging from 1:3 to 1:300, and to authorize the Company’s Board of Directors to determine, at its discretion, the timing of the amendment and the specific ratio of the reverse stock split); and
https://www.otcmarkets.com/filing/html?id=16916729&guid=Xig-kp5kxDnKJth
LIFW, may file Bankruptcy soon, 6 month revenue; $2.5 m, while Loss: $385 Million, Bankruptcy already !!!
FWBI, Bad news: Financing at $0.43: LOL!
2023-09-14 10:44 ET - News Release
BOCA RATON, Fla., Sept. 14, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (“First Wave BioPharma” or the “Company”) (NASDAQ: FWBI), a clinical-stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, today announced it has entered into agreements with certain holders of its existing warrants exercisable for 5,882,036 shares of its common stock, in the aggregate, to exercise their warrants at a reduced exercise price of $0.43 per share, in exchange for new warrants as described below. The aggregate gross proceeds from the exercise of the existing warrants is expected to total approximately $4.0 million, before deducting financial advisory fees. The reduction in the exercise price of the existing warrants and the issuance of the new warrants was structured as an at-market transaction under Nasdaq rules.
AWIN, $0.18. It was $18 in Feb.
AWIN, $0.18. It was $18 in Feb. LOL!
AWIN, from $18 to $0.18, Great run!
AWIN, from $18 to $0.18, Great run!
AWIN, from $18 to $0.18, Great run!
AWIN, cash: $35k, Loss; $19 Million, Will file Bankruptcy SOON!
10-Q:
https://www.otcmarkets.com/filing/html?id=16879201&guid=Xig-kp5kxDnKJth
AWIN, cash: $35k, Loss; $19 Million, Will file Bankruptcy SOON!
10-Q:
https://www.otcmarkets.com/filing/html?id=16879201&guid=Xig-kp5kxDnKJth
They're pumping to Dump before it'll file Bankruptcy Soon! Be careful.
Wow! LIFW, revenue; $2.5 m, while Loss: $385 Million, Bankruptcy!!!
AWIN, a dead cat pump and dump before its death. LOL.
Huge volumes again today.
FWBI, O/S, only 7 m, tiny. High $7.5 in Feb. Now, traded 11 million shares.
FWBI, amazing news with Sanofi (a huge pharmaceutical company) just out
FINRA will Never let AWON scam to uplist to OTCQB, BECAUSE it's a Scam.
You mean ACB will do another Reverse Splits?
EZGO, was $2.46 on Sep 1.
EZGO, Offering cancelled. Bouncing back to $1+.
What are its current O/S? Thanks.
And you can also have triple DOWN to $0.05 Again with this stinky SCaM!
ACB, good run, $0.77, bought at $0.58 this morning.
Warning; BLMS, diluting 225 Million shares:
https://www.otcmarkets.com/filing/html?id=16738703&guid=MOg-kqt7kD7fJth
Warning; ILAL, a Pump and dump Scam; cash: $52k, Loss: $2.3 Million as of June 30. While it had $3.2 Million Loss last year. It'll be shut down soon with so huge losses and no revenues.
https://www.otcmarkets.com/filing/html?id=16877047&guid=MOg-kqt7kD7fJth
MDV, $15.9, up $3.
AXLA, $1.04, my 0.30 tripled . Great!!!